Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Revenue:
Total revenues	$ 0	$ 0	$ 0	$ 0
Operating expenses:
Research and development	516,672	443,380	1,535,370	1,495,201
General and administrative	542,697	489,545	1,896,230	1,357,044
Total operating expenses	1,059,369	932,925	3,431,600	2,852,245
Loss from operations	(1,059,369)	(932,925)	(3,431,600)	(2,852,245)
Interest income	0	7,036	3,926	23,927
Loss before income tax benefit	(1,059,369)	(925,889)	(3,427,674)	(2,828,318)
Provision for income tax benefit	614,362	0	614,362	0
Net loss	(445,007)	(925,889)	(2,813,312)	(2,828,318)
Other comprehensive loss:
Foreign currency translation adjustment	(25,834)	(38,626)	(48,986)	(311,718)
Comprehensive loss	$ (470,841)	$ (964,515)	$ (2,862,298)	$ (3,140,036)
Net loss per share, basic and diluted	$ (0.02)	$ (0.05)	$ (0.14)	$ (0.16)
Weighted average number of common shares outstanding	20,808,050	20,540,709	20,798,013	17,217,952